Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treximet for Acute Migraine in Adolescents
NCT00843024Phase 3Completed
- Sponsor
- GSK
- Start
- Dec 2008
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of sumatriptan + naproxen sodium in migraine (4 arms), sponsored by GSK. Primary endpoint: Number of Participants Who Were Pain Free at 2 Hours Post-dose. Started Dec 2008; status: completed.
02
Drugs
sumatriptan + naproxen sodium
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00843024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00843024.